Abivax SA American Depositary Shares (ABVX) — Cash Flow-to-Debt Ratio
Abivax SA American Depositary Shares (ABVX) has a Cash Flow-to-Debt Ratio of -0.55x as of December 2025, meaning its operating cash flow of $-71.28 Million could theoretically repay -1% of its total liabilities ($129.08 Million) in one year. See working capital to net assets of Abivax SA American Depositary Shares to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Abivax SA American Depositary Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Abivax SA American Depositary Shares across 12 annual periods. Also explore net asset growth rate of Abivax SA American Depositary Shares to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Abivax SA American Depositary Shares (2014–2025)
Year-by-year debt coverage analysis for Abivax SA American Depositary Shares. For market capitalisation and broader financial context, see ABVX market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.21x | $-155.69 Million | $129.08 Million | ▼ -28.9% |
| 2024 | -0.94x | $-154.07 Million | $164.64 Million | ▼ -22.6% |
| 2023 | -0.76x | $-100.01 Million | $131.05 Million | ▲ +3.3% |
| 2022 | -0.79x | $-53.94 Million | $68.36 Million | ▼ -44.0% |
| 2021 | -0.55x | $-45.66 Million | $83.30 Million | ▲ +1.9% |
| 2020 | -0.56x | $-29.82 Million | $53.40 Million | ▲ +32.6% |
| 2019 | -0.83x | $-27.47 Million | $33.14 Million | ▼ -10.1% |
| 2018 | -0.75x | $-14.60 Million | $19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | $-8.45 Million | $5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | $-15.61 Million | $3.88 Million | ▼ -21.5% |
| 2015 | -3.31x | $-14.90 Million | $4.50 Million | ▼ -304.0% |
| 2014 | -0.82x | $-3.31 Million | $4.03 Million | — |